ARCHIVES

More Cost-Effective To Use Cetuximab In Patients With Wild-Type KRAS Gene

This article is from The Cancer Letter archive.

Vol. 32 No. 8 | August 28, 2009

Download PDF Visit The Full Archive

Related Articles

Obesity, Faster Weight Gain, Linked To Poor Prognosis

October 28, 2005

Budge Act Includes Language On Coverage Of Oral Cancer Drugs

August 13, 1993

Clinical Study Section’s Workload Up 50 Percent, Evidence That More Investigators Submitting R01s

January 17, 1992

Sieber Direct Communications At NCI, Reorganizing Offices.

March 31, 2000

Rich Left AMC “For Personal Reasons”

April 21, 1989

New Technology May Enable Therapy Tailored To Patient’s Predicted Response

April 26, 2002